179 related articles for article (PubMed ID: 28813246)
21. An opportunity for clinical pharmacology trained physicians to improve patient drug safety: A retrospective analysis of adverse drug reactions in teenagers.
Eugene AR; Eugene B
F1000Res; 2018; 7():677. PubMed ID: 30271581
[No Abstract] [Full Text] [Related]
22. Miscategorization of Deaths in the US Food and Drug Administration Adverse Events Database.
Meier L; Wang EY; Tomes M; Redberg RF
JAMA Intern Med; 2020 Jan; 180(1):147-148. PubMed ID: 31589249
[TBL] [Abstract][Full Text] [Related]
23. Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database.
Fujimoto M; Higuchi T; Hosomi K; Takada M
Int J Med Sci; 2015; 12(3):223-33. PubMed ID: 25678839
[TBL] [Abstract][Full Text] [Related]
24. Comparing Different Adverse Effects Among Multiple Drugs Using FAERS Data.
Huang J; Zhang X; Du J; Duan R; Yang L; Moore JH; Chen Y; Tao C
Stud Health Technol Inform; 2017; 245():1268. PubMed ID: 29295353
[TBL] [Abstract][Full Text] [Related]
25. Mini-Sentinel and regulatory science--big data rendered fit and functional.
Psaty BM; Breckenridge AM
N Engl J Med; 2014 Jun; 370(23):2165-7. PubMed ID: 24897081
[No Abstract] [Full Text] [Related]
26. Automatic detection of adverse events to predict drug label changes using text and data mining techniques.
Gurulingappa H; Toldo L; Rajput AM; Kors JA; Taweel A; Tayrouz Y
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1189-94. PubMed ID: 23935003
[TBL] [Abstract][Full Text] [Related]
27. Association between Benzodiazepine Use and Dementia: Data Mining of Different Medical Databases.
Takada M; Fujimoto M; Hosomi K
Int J Med Sci; 2016; 13(11):825-834. PubMed ID: 27877074
[No Abstract] [Full Text] [Related]
28. Mining Drugs and Indications for Suicide-Related Adverse Events.
Ding T; Chen ES
AMIA Annu Symp Proc; 2019; 2019():1011-1020. PubMed ID: 32308898
[TBL] [Abstract][Full Text] [Related]
29. Filing Sources after Oral P2Y12 Platelet Inhibitors to the Food and Drug Administration Adverse Event Reporting System (FAERS).
Serebruany VL; Cherepanov V; Kim MH; Litvinov O; Cabrera-Fuentes HA; Marciniak TA
Cardiology; 2017; 138(4):249-253. PubMed ID: 28898876
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases].
Sasaoka S; Matsui T; Abe J; Umetsu R; Kato Y; Ueda N; Hane Y; Motooka Y; Hatahira H; Kinosada Y; Nakamura M
Yakugaku Zasshi; 2016; 136(3):507-15. PubMed ID: 26935094
[TBL] [Abstract][Full Text] [Related]
31. Scientists mine web search data to identify epidemics and adverse events.
Kuehn BM
JAMA; 2013 May; 309(18):1883-4. PubMed ID: 23652502
[No Abstract] [Full Text] [Related]
32. More eyeballs on AERS.
Pratt LA; Danese PN
Nat Biotechnol; 2009 Jul; 27(7):601-2. PubMed ID: 19587659
[No Abstract] [Full Text] [Related]
33. FDA turns to electronic "sentinel" to flag prescription drug safety problems.
Kuehn BM
JAMA; 2008 Jul; 300(2):156-7. PubMed ID: 18612108
[No Abstract] [Full Text] [Related]
34. Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS).
Zhang X; Hamadeh IS; Song S; Katz J; Moreb JS; Langaee TY; Lesko LJ; Gong Y
J Bone Miner Res; 2016 Feb; 31(2):336-40. PubMed ID: 26288087
[TBL] [Abstract][Full Text] [Related]
35. Information-Derived Mechanistic Hypotheses for Structural Cardiotoxicity.
Svensson F; Zoufir A; Mahmoud S; Afzal AM; Smit I; Giblin KA; Clements PJ; Mettetal JT; Pointon A; Harvey JS; Greene N; Williams RV; Bender A
Chem Res Toxicol; 2018 Nov; 31(11):1119-1127. PubMed ID: 30350600
[TBL] [Abstract][Full Text] [Related]
36. FDA's sentinel network: a monumental task.
Young D
Am J Health Syst Pharm; 2007 Apr; 64(8):800-1. PubMed ID: 17420189
[No Abstract] [Full Text] [Related]
37. Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.
de Bie S; Ferrajolo C; Straus SM; Verhamme KM; Bonhoeffer J; Wong IC; Sturkenboom MC;
PLoS One; 2015; 10(6):e0130399. PubMed ID: 26090678
[TBL] [Abstract][Full Text] [Related]
38. Drugs associated with serum sickness and serum sickness-like reactions: A review of FDA Adverse Event Reporting System (FAERS) data.
Surdacki M; Fernandez E; Phillips EJ; Stone CA
J Allergy Clin Immunol Pract; 2024 May; 12(5):1351-1354.e1. PubMed ID: 38462072
[No Abstract] [Full Text] [Related]
39. Statin-associated lower urinary tract symptoms: data mining of the public version of the FDA adverse event reporting system, FAERS.
Fujimoto M; Hosomi K; Takada M
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):259-66. PubMed ID: 24472404
[TBL] [Abstract][Full Text] [Related]
40. Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
Alatawi YM; Hansen RA
Expert Opin Drug Saf; 2017 Jul; 16(7):761-767. PubMed ID: 28447485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]